Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529

Marie Pancera, Yen Ting Lai, Tatsiana Bylund, Aliaksandr Druz, Sandeep Narpala, Sijy O'Dell, Arne Schön, Robert T. Bailer, Gwo Yu Chuang, Hui Geng, Mark K. Louder, Reda Rawi, Djade I. Soumana, Andrés Finzi, Alon Herschhorn, Navid Madani, Joseph Sodroski, Ernesto Freire, David R. Langley, John R. MascolaAdrian B. McDermott, Peter D. Kwong

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


The HIV-1 envelope (Env) spike is a conformational machine that transitions between prefusion (closed, CD4- and CCR5-bound) and postfusion states to facilitate HIV-1 entry into cells. Although the prefusion closed conformation is a potential target for inhibition, development of small-molecule leads has been stymied by difficulties in obtaining structural information. Here, we report crystal structures at 3.8-Å resolution of an HIV-1-Env trimer with BMS-378806 and a derivative BMS-626529 for which a prodrug version is currently in Phase III clinical trials. Both lead candidates recognized an induced binding pocket that was mostly excluded from solvent and comprised of Env elements from a conserved helix and the β20-21 hairpin. In both structures, the β20-21 region assumed a conformation distinct from prefusion-closed and CD4-bound states. Together with biophysical and antigenicity characterizations, the structures illuminate the allosteric and competitive mechanisms by which these small-molecule leads inhibit CD4-induced structural changes in Env.

Original languageEnglish (US)
Pages (from-to)1115-1122
Number of pages8
JournalNature Chemical Biology
Issue number10
StatePublished - Oct 1 2017

Bibliographical note

Funding Information:
We thank J. Stuckey for assistance with figures, members of Structural Biology and Structural Bioinformatics Core Sections, Vaccine Research Center for discussions and comments on the manuscript. We thank J. Baalwa (University of Alabama at Birmingham), D. Ellenberger (National Cancer Institute, NIH), F. Gao (Duke University), B. Hahn (University of Pennsylvania), K. Hong (Chinese Center for Disease Control and Prevention), J. Kim (The International Vaccine Institute), F. McCutchan (Military HIV Research Program), D. Montefiori (Duke University), L. Morris (National Institute of Communicable Diseases), J. Overbaugh (Fred Hutchison Cancer Research Center), E. Sanders-Buell (Military HIV Research Program), G. Shaw (University of Pennsylvania), R. Swanstrom (University of North Carolina at Chapel Hill), M. Thomson (Instituto de Salud Carlos III), S. Tovanabutra (Military HIV Research Program), C. Williamson (University of Cape Town) and L. Zhang (China Medical University Shenyang) for contributing the HIV-1 envelope plasmids used in our neutralization panel. We thank D. Burton (The Scripps Research Institute) and M. Feinberg (International AIDS Vaccine Initiative) for antibody PGT122 and M. Connors (National Institute of Allergy and Infectious Diseases, NIH) for antibody 35O22 used in structural analysis. Funding was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, the Intramural AIDS Targeted Antiretroviral Program, the National Institute of General Medical Sciences, National Institutes of Health (J.S.), the National Science Foundation MCB-1157506 (E.F.) and the National Institutes of Health GM56550 (E.F.). Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38.

Publisher Copyright:
© 2017 Nature America, Inc., part of Springer Nature. All rights reserved.


Dive into the research topics of 'Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529'. Together they form a unique fingerprint.

Cite this